Regeneron Pharmaceuticals (REGN) Other financing activities (2010 - 2025)
Regeneron Pharmaceuticals' quarterly Other financing activities came in at -$10.3 million in Q1 2025, up 69.16% quarter-over-quarter from -$33.4 million in Q3 2024.
Regeneron Pharmaceuticals has reported Other financing activities for 9 years, with the latest figure at -$10.3 million in Q1 2025.
- For the quarter ending Q1 2025, Other financing activities changed N/A year-over-year to -$10.3 million; the trailing twelve-month figure through Dec 2025 stood at -$10.3 million (up 69.16% YoY), and the FY2025 full-year result was -$10.3 million, up 69.16% from the prior year.
- Other financing activities for Q1 2025 stood at -$10.3 million, up from -$33.4 million in the prior quarter.
- The five-year high for Other financing activities was -$10.3 million in Q1 2025, with the low at -$33.4 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -10.30 Mn |
| Mar 31, 2025 | -10.30 Mn |
| Sep 30, 2024 | -33.40 Mn |
| Sep 30, 2024 | -33.40 Mn |
| Sep 30, 2016 | 8.60 Mn |
| Sep 30, 2016 | 8.60 Mn |
| Jun 30, 2016 | 39.80 Mn |
| Jun 30, 2016 | 39.80 Mn |
| Mar 31, 2016 | 15.60 Mn |
| Mar 31, 2016 | 15.60 Mn |
| Dec 31, 2015 | 99.77 Mn |
| Dec 31, 2015 | 99.77 Mn |
| Sep 30, 2015 | 56.83 Mn |
| Sep 30, 2015 | 56.83 Mn |
| Jun 30, 2015 | 78.92 Mn |
| Jun 30, 2015 | 78.92 Mn |
| Mar 31, 2015 | 169.79 Mn |
| Mar 31, 2015 | 169.79 Mn |
| Dec 31, 2014 | 105.13 Mn |
| Dec 31, 2014 | 105.13 Mn |
| Sep 30, 2014 | 98.57 Mn |
| Sep 30, 2014 | 98.57 Mn |
| Jun 30, 2014 | 118.32 Mn |
| Jun 30, 2014 | 118.32 Mn |
| Mar 31, 2014 | 117.26 Mn |
| Mar 31, 2014 | 117.26 Mn |
| Dec 31, 2013 | 114.07 Mn |
| Dec 31, 2013 | 114.07 Mn |
| Sep 30, 2013 | 89.96 Mn |
| Sep 30, 2013 | 89.96 Mn |
| Jun 30, 2013 | 5.58 Mn |
| Jun 30, 2013 | 5.58 Mn |
| Mar 31, 2013 | 2.29 Mn |
| Mar 31, 2013 | 2.29 Mn |
| Jun 30, 2012 | 12.37 Mn |
| Jun 30, 2012 | 12.37 Mn |
| Mar 31, 2012 | 49.08 Mn |
| Mar 31, 2012 | 49.08 Mn |
| Dec 31, 2011 | -3.41 Mn |
| Dec 31, 2011 | -3.41 Mn |
| Sep 30, 2011 | -1.30 Mn |
| Sep 30, 2011 | -1.30 Mn |
| Jun 30, 2011 | 1.30 Mn |
| Jun 30, 2011 | 1.30 Mn |
| Mar 31, 2011 | 3.41 Mn |
| Mar 31, 2011 | 3.41 Mn |
| Mar 31, 2010 | 2.87 Mn |
| Mar 31, 2010 | 2.87 Mn |